RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,037 | -32.6% | 25,807 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $321,875 | -22.5% | 25,627 | +1.6% | 0.00% | 0.0% |
| Q1 2023 | $415,324 | +10.2% | 25,217 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $376,742 | -48.0% | 25,217 | -22.2% | 0.00% | -50.0% |
| Q3 2022 | $725,000 | +33.5% | 32,417 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $543,000 | +6.3% | 32,417 | +89.8% | 0.00% | 0.0% |
| Q1 2022 | $511,000 | -2.5% | 17,077 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $524,000 | +15.2% | 17,077 | +18.4% | 0.00% | 0.0% |
| Q3 2021 | $455,000 | -12.0% | 14,426 | +2.1% | 0.00% | 0.0% |
| Q2 2021 | $517,000 | +53.9% | 14,126 | +45.3% | 0.00% | 0.0% |
| Q1 2021 | $336,000 | +15.9% | 9,720 | +39.5% | 0.00% | 0.0% |
| Q4 2020 | $290,000 | – | 6,970 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |